Affiliation:
1. Belarusian State Medical University
Abstract
The anti-inflammatory properties of the combination of meloxicam and atypical NSAID N-acetyl-L-proline (Groceprol®) after intragastric administration in a model of carrageenan paw edema in mice were studied. The average effective dose of N-acetyl-L-proline calculated by the regression analysis method in this model was 414 mg/kg, and the average effective dose of meloxicam was 2.85 mg/kg. In the combination in a ratio of 40:1, the activity of the compounds increases significantly, the ED50 of meloxicam decreases to 1 mg/kg, a similar value of N-acetyl-L-proline becomes 43 mg/kg. The same trend was also observed with another mass ratio of components of 20:1. The analysis of the pharmacodynamics of the combination of drugs according to the T. Chou method showed an additive type of interaction, typical for compounds with different mechanisms of primary action. It was established that a combination of N-acetyl-L-proline and meloxicam in the weight ratios of 40:1 and 20:1 demonstrate synergism, allowing to reduce the dose of the components in 2.7–9.6 times as compared with the effect of the drugs individually.The results of the study are the experimental justification for the use of anti-inflammatory synergistic combination of N-acetyl-L-proline and meloxicam.
Publisher
Publishing House Belorusskaya Nauka
Reference12 articles.
1. Rainsford K. D. Aspirin and related drugs. London, Taylor and Francis, 2004. 800 p.
2. Zabłocka A., Janusz M., Macała J., Lisowski J. A proline-rich polypeptide complex (PRP) isolated from ovine colostrum. Modulation of H 2O2 and cytokine induction in human leukocytes. International Immunopharmacology, 2007, vol. 7, no. 7, pp. 981–988. https://doi.org/10.1016/j.intimp.2007.02.012
3. Ionac M., Parnham M. J., Plauchithiu M., Brune K. Oxaceprol, an atypical inhibitor of inflammation and joint damage. Pharmacological Research, 1996, vol. 33, no. 6, pp. 367–373. https://doi.org/10.1006/phrs.1996.0051
4. Parnham M. J. Antirheumatic agents and leukocyte recruitment. New light on the mechanism of action of oxaceprol. Biochemical Pharmacology, 1999, vol. 58, no. 2, pp. 209–215. https://doi.org/10.1016/s0006-2952(99)00056-8
5. Riera H., Barbara A., Aprile F., Maheu E., Mitrovic D. Effect of oxaceprol on the synthesis and degradation in vitro of proteoglycans and proteins by calf articular cartilage explants. Revue du rhumatisme et des maladies ostéo-articulaires, 1990, vol. 57, pp. 579–583.